oncologypro.esmo.orgOncologyPRO | Educational Portal for Oncologists

Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly. MINIMAL Requirements: Google Chrome 24+ , Mozilla Firefox 20+ , Internet Explorer 11 , Opera 15–18 , Apple Safari 7 , SeaMonkey 2.15-2.23 ESMO OncologyPRO 30k 49k 5.5k 30K 7K Login Search Search Oncology News Daily News ESMO Videos What is new on Oncology PRO Education Library ESMO E-Learning and V-Learning Essentials for Clinicians Gastrointestinal Tract Tumours Sarcoma & GIST plus CUP Genitourinary Tract Tumours Thoracic Tumours Leukaemia and Myeloma Breast Cancer Neuro-Oncology Head & Neck Cancers Gynaecological Tumours Lymphomas ESMO Handbooks Immuno-Oncology Interpreting Oncological Study Publications Oncological Emergencies Cancer Diagnosis and Treatment Evaluation Cancer in the Senior Patient Translational Research Rehabilitation Issues During Cancer Treatment and Follow-Up Cancer Treatment in Special Clinical Situations Clinical Pharmacology of Anti-Cancer Agents Nutrition and Cancer Advanced Cancer Care Cancer Prevention ESMO Handbooks for E-readers ESMO Oncology Journals Factsheets on Biomarkers Factsheets on Anti-Cancer Agents ESMO Webinar Series ESMO Podcasts Glossary of Precision Medicine Glossary of Molecular Biology Contributors Glossary of Medical Terms Clinical Trial Resources Tips and Tricks ESMO Clinical Trials Course Resources from ESMO Meetings Useful Links User’s Manual for Oncology Clinicians Global Curriculum in Medical Oncology Abbreviations Links to Cancer Journals Oncology Journals Open Access Oncology Journals Biomarker Journals Haematology Journals Cancer in Medical Journals Oncology Articles in BMJ Oncology Articles in Nature Medicine Oncology Articles in the NEJM Oncology Articles in the JAMA Oncology Articles in The Lancet Annals of Oncology: Editor's Choice ESMO Members: Build Your Own ESMO Library Oncology in practice Practice Tools How To videos ESMO Checklists Colorectal Cancer Prognosis International Prognostic Index Tools for Lymphoma Germ Cell Tumours Risk Groups Hasenclever-Index for Hodgkin's Disease Performance Scales Anti-Cancer Agents and Biological Therapy Drug-Drug Interactions with Kinase Inhibitors PARP inhibition and DNA Damage Response (DDR) Targeting NTRK Gene Fusions Bioethics, legal and economic issues Cancer Aetiology, Epidemiology and Prevention Cancer Immunology and Immunotherapy Cancer in Special situations (pregnancy, young, elderly, hereditary...) Cancer in Adolescents and Young Adults Cancer in Pregnancy Geriatric Oncology Imaging, Diagnosis and Staging Palliative and Supportive care EGFRI-Related Skin Toxicity Multikinase Inhibitor-Related Skin Toxicity Pathology and Molecular Biology Precision Medicine and Validated Biomarkers ESMO Recommendations in Precision Medicine Surgery and / or Radiotherapy Translational Research: Biomarkers & Diagnostics Gene and Cell Therapy e-School Rare Cancers Resources for Patients Guidelines Meeting resources Tumour Sites Breast Cancer Carcinoma of Unknown Primary Site Central Nervous System Malignancies Endocrine Cancers Neuroendocrine Cancer Gastrointestinal Cancers Lower Gastrointestinal Cancers Upper Gastrointestinal Cancers Genitourinary Cancers Prostate Cancer Gynaecological Malignancies Ovarian Cancer Haematological Malignancies Lymphomas Head and Neck Cancers Lung and other Thoracic Tumours Non-Small Cell Lung Cancer Melanoma and other Skin Tumours Sarcomas ESMO OncologyPRO Login 30k 49k 5.5k 30K 7K Welcome to OncologyPRO, the home of Esmo’s educational and scientific resources. OncologyPRO is supported by our valued sponsors. Our sponsors ESMO Preceptorships programme webcasts Find here courses for each tumour type and general topic! All slides and webcasts are open access with a free ESMO account Read More ESMO Guidelines: Real World Cases - Webinar Series Watch the recordings! Open access with a free ESMO account Read More ESMO Virtual Plenary Resources Accelerating Research to Practice: On-demand slides and webcasts are Open access with a free ESMO account. Watch the recording from 8th April session! Read More What's new on OncologyPRO Haven't had much time lately? Here's what you may have missed in the last few weeks. MORE RECENTLY PUBLISHED CONTENT ... ESMO Guidelines: Real World Cases - Webinar Series: Chronic Lymphocytic Leukaemia 27 Apr 2021 ESMO Course ESMO Virtual Preceptorship on Colorectal Cancer 2021 16 Apr 2021 12 Apr 2021 Hepatobiliary Cancers; Personalised/Precision Medicine FGFR2 Fusions Testing in Intrahepatic Cholangiocarcinoma: ESMO Biomarker Factsheet Nicola Normanno ESMO Course ESMO Virtual Advanced Course on Clinical Questions in Prostate Cancer 2021 25 Mar 2021 Virtual Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small cell lung cancer (Nsq-NSCLC) with high PD-L1 expression using real-world data 08 Apr 2021 ESMO Virtual Congress 2020 Abstracts, webcasts, slides, news articles and video interviews from ESMO Virtual Congress 2020. Access resources ESMO Guidelines Discover more Get OncologyPRO updates every two weeks! Subscribe to receive our newsletter including only new content just published. Sign up COVID-19 and Cancer Find recommendations, materials and resources to support oncology professionals in their delivery of quality cancer care. Read more Scientific Videos Expert Report on novel targeted treatments from AACR Annual Meeting 2021 30 Apr 2021 Read more Expert video report on Urothelial Carcinoma from 2021 Genitourinary Cancers Symposium 23 Feb 2021 Read more Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium 23 Feb 2021 Read more Expert video report NTRK gene fusions in oncology 14 Jan 2021 Read more Expert Video Report on hematologic aspects of the Covid 19 pandemic from ASH 2020 08 Jan 2021 Read more Expert Video Report on Acute Myeloid Leukemia and high risk MDS from ASH 2020 06 Jan 2021 Read more ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC 01 Oct 2020 Read more ESMO 2020 Expert Video Report on ovarian cancer 01 Oct 2020 Read more All videos on the ESMO Channel: Subscribe now! Latest Oncology News 30 Apr 2021 Prompt Second BNT162b2 Dose Recommended For Cancer Patients Cancer patients should be given their second dose of the BNT162b2 vaccine 21 days after their first to ensure protection from SARS-CoV-2 infection Read more 27 Apr 2021 Carboplatin–Paclitaxel Recommended For Elderly Advanced Ovarian Cancer Patients Carboplatin–paclitaxel is superior to single-agent carboplatin for FIGO stage III–IV ovarian cancer in women with a high Geriatric Vulnerability Score Read more 23 Apr 2021 Alisertib Combination May Boost Metastatic Breast Cancer PFS Adding alisertib to paclitaxel chemotherapy may improve progression-free survival for patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer Read more 21 Apr 2021 Aneuploidy May Predict NSCLC Immunotherapy Response Non-small-cell lung cancer response to immune checkpoint inhibitor therapy may be linked to the number of chromosomal arm alterations present Read more 16 Apr 2021 Adding Copanlisib To Rituximab Improves PFS In Relapsed Indolent NHL Phase III data suggest that combining copanlisib with rituximab could be an option for patients with indolent non-Hodgkin lymphoma who have progressed on at least one prior rituximab-based therapy Read more 15 Apr 2021 Early Data Highlight Bispecific CAR T-Cell Therapy Potential For B-Cell Lymphomas Patients with relapsed or refractory B-cell lymphomas may benefit from treatment with bispecific CAR T-cell therapy directed against CD19 and CD20 Read more 13 Apr 2021 CheckMate 816 Shows Benefit Of Neoadjuvant Nivolumab–Chemotherapy For Operable NSCLC Neoadjuvant nivolumab plus chemotherapy could be an option for individuals with early-stage, resectable non-small-cell lung cancer Read more 12 Apr 2021 Oncolytic Virotherapy ‘Potential’ Demon...